Circulating Exosomal CircMYC Is Associated with Recurrence and Bortezomib Resistance in Patients with Multiple Myeloma

Circulating Exosomal CircMYC Is Associated with Recurrence and Bortezomib Resistance in Patients with Multiple Myeloma

Objective: Studies have shown that serum circRNA can be used as a biomarker for many tumors. However, the role of exosomal circRNA in prognostic evaluation in patients with multiple myeloma (MM) remains unclear. In this study, we aimed to analyze the role of circulating exosomal circMYC in the relap...

Full description

Bibliographic Details
Main Authors:	Yanwei Luo, Rong Gui
Format:	Article
Language:	English
Published:	Galenos Publishing House 2020-11-01
Series:	Turkish Journal of Hematology
Subjects:	circular rna biomarker drug resistance overall survival hematological tumor
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-09634

Similar Items

The emerging landscape of exosomal CircRNAs in solid cancers and hematological malignancies
by: Qinfeng Zhou, et al.
Published: (2022-05-01)

Bortezomib (velcade) plus melphalan and prednisone in elderly untreated patients with multiple myeloma
by: S. S. Bessmeltsev, et al.
Published: (2022-11-01)

Clinicopathologic significance and prognostic value of circRNAs in osteosarcoma: a systematic review and meta-analysis
by: Jingyu Zhong, et al.
Published: (2021-10-01)

Survival and Prognosis Analysis of Bortezomib Based Regimen in Newly Diagnosed Super-aged Multiple Myeloma Patients
by: ZHAO Fengyi, LI Xin, ZHAN Xiaokai, ZHANG Jiajia, SHEN Man, TANG Ran, FAN Sibin, HUANG Zhongxia
Published: (2024-03-01)

ISG20L2 suppresses bortezomib antimyeloma activity by attenuating bortezomib binding to PSMB5
by: Yan Yang, et al.
Published: (2022-10-01)

Bortezomib (Velcade) in combination with dexamethasone eor relapsed or refractory myeloma
by: S. S. Bessmeltsev, et al.
Published: (2022-11-01)

Circular Noncoding RNA hsa_circ_0003570 as a Prognostic Biomarker for Hepatocellular Carcinoma
by: Se Young Jang, et al.
Published: (2022-08-01)

The Effect of Bortezomib Regimen on Multiple Myeloma Patients Infected with COVID-19
by: Zahra Rezaeian, et al.
Published: (2023-10-01)

The Relationship between Serum miRNAs and Early Mortality in Multiple Myeloma Patients Treated with Bortezomib-Based Regimens
by: Anna Puła, et al.
Published: (2023-02-01)

Exosomal circRNAs in the plasma serve as novel biomarkers for IPF diagnosis and progression prediction
by: Wenhua Gan, et al.
Published: (2024-03-01)

Safety and Efficacy of Doxorubicin, Cyclophosphamide, Bortezomib, Dexamethasone and Lenalidomide Followed by Bortezomib Consolidation as First-Line Therapy in Patients with Newly Diagnosed Multiple Myeloma
by: Kristian T. Andersen, et al.
Published: (2020-01-01)

Urinary exosomal hsa_circ_0001250 as a novel diagnostic biomarker of idiopathic membranous nephropathy
by: Qianyu Li, et al.
Published: (2022-12-01)

Systematic Analysis of Chemokines Reveals CCL18 is a Prognostic Biomarker in Glioblastoma
by: Gao W, et al.
Published: (2022-04-01)

Circulating Tumor Cells in Pancreatic Cancer: Current Perspectives
by: Verena Martini, et al.
Published: (2019-10-01)

Management of Recurrent Meningiomas: State of the Art and Perspectives
by: Marco Vincenzo Corniola, et al.
Published: (2022-08-01)

A Novel Prognostic Model Predicts Outcomes in Non-Metastatic Nasopharyngeal Carcinoma Based on Inflammation, Nutrition, and Coagulation Signature
by: Chen LZ, et al.
Published: (2023-11-01)

EPIDEMIOLOGY OF MULTIPLE MYELOMA ACCORDING TO THE КIROV REGION POPULATION REGISTERS
by: A. S. Luchinin, et al.
Published: (2017-10-01)

Plasma exosome-derived circGAPVD1 as a potential diagnostic marker for colorectal cancer
by: Tiankang Li, et al.
Published: (2023-05-01)

Advances in the Study of circRNAs in Hematological Malignancies
by: Jingyi Du, et al.
Published: (2022-06-01)

The Danish National Multiple Myeloma Registry
by: Gimsing P, et al.
Published: (2016-10-01)

Systematic Review of Preoperative Prognostic Biomarkers in Perihilar Cholangiocarcinoma
by: Rishaan Pawaskar, et al.
Published: (2024-02-01)

CT-based radiomics combined with hematologic parameters for survival prediction in locally advanced esophageal cancer patients receiving definitive chemoradiotherapy
by: Jinfeng Cui, et al.
Published: (2024-03-01)

Assessing the prognostic utility of hematologic response for overall survival in patients with newly diagnosed AL amyloidosis: results of a meta-analysis
by: Efstathios Kastritis, et al.
Published: (2023-12-01)

Development and validation of a prognostic nomogram model incorporating routine laboratory biomarkers for preoperative patients with endometrial cancer
by: Rong Cong, et al.
Published: (2023-11-01)

Prediction of Early Response to Immunotherapy: DCE-US as a New Biomarker
by: Raphael Naccache, et al.
Published: (2022-03-01)

Intermediate endpoints as surrogates for outcomes in cancer immunotherapy: a systematic review and meta-analysis of phase 3 trialsResearch in context
by: Zhishan Zhang, et al.
Published: (2023-09-01)

Downregulation of STOX1 is a novel prognostic biomarker for glioma patients
by: Jin Fei-qin, et al.
Published: (2021-10-01)

The effects of dexmedetomidine on postoperative tumor recurrence and patient survival after breast cancer surgery: a feasibility study
by: Jiamei Luo, et al.
Published: (2023-11-01)

A circRNA signature predicts postoperative recurrence in stage II/III colon cancer
by: Huai‐Qiang Ju, et al.
Published: (2019-10-01)

Circular RNAs hsa-circ0000175 and hsa-circ0044235 in plasma are novel biomarkers for new-onset rheumatoid arthritis
by: Yujie Gao, et al.
Published: (2021-05-01)

A prognostic model for patients with primary extramedullary multiple myeloma
by: Limei Zhang, et al.
Published: (2022-11-01)

Biomarkers of related driver genes predict anti-tumor efficacy of immune checkpoint inhibitors
by: Shuai Jiang, et al.
Published: (2022-09-01)

Body Mass Index and Overall Survival of Patients with Newly Diagnosed Multiple Myeloma
by: Bei Wang, et al.
Published: (2022-10-01)

Comprehensive analysis of prognosis of cuproptosis-related oxidative stress genes in multiple myeloma
by: Tingting Li, et al.
Published: (2023-03-01)

Modern strategies in therapy of elderly patients with multiple myeloma
by: S. S. Bessmeltsev, et al.
Published: (2022-11-01)

The Potential Role of Circulating Long Miscellaneous RNAs in the Diagnosis and Prognosis of Hepatitis C Related Hepatocellular Carcinoma
by: Shimaa Abdelsattar, et al.
Published: (2023-10-01)

Prognostic impact of the controlling nutritional status score in patients with hematologic malignancies: A systematic review and meta-analysis
by: Chuanyang Lu, et al.
Published: (2022-10-01)

Circulating Exosomal CircRNAs as Diagnostic Biomarkers for Chronic Coronary Syndrome
by: Xiaoyan Liu, et al.
Published: (2023-10-01)

Taxifolin Inhibits Breast Cancer Growth by Facilitating CD8+ T Cell Infiltration and Inducing a Novel Set of Genes including Potential Tumor Suppressor Genes in 1q21.3
by: Xiaozeng Lin, et al.
Published: (2023-06-01)

Integrated profiling identifies CACNG3 as a prognostic biomarker for patients with glioma
by: Enfang Shan, et al.
Published: (2023-09-01)